Source:
Summary
Johnson & Johnson Chairman and CEO Joaquin Duato predicts a cure for cancer could be on the horizon in the next decade. Duato shared this goal at the WSJ Leadership Institute CEO Summit in London, citing progress in certain cancers, such as multiple myeloma. He noted that treatments utilizing the immune system to attack cancer have shown promising results, with some patients experiencing remission after a single administration. Duato also emphasized the company’s efforts to understand the biology of cancer growth and develop new technologies to address it.
Our Reading
The advice sounds familiar.
Johnson & Johnson’s goal to “try to eliminate cancer” in the next 10 years is an ambitious one, building on recent progress in certain cancers. The use of AI and biomarkers may help with earlier diagnoses and targeted treatments. However, the complexity of cancer growth and the need for continued research and development are also acknowledged. As one expert noted, some cancers may become chronic diseases, while others may find outright cures.
The promise of a cure for cancer has been heard before, and the timeline for achieving it has been revised multiple times.
Author: Evan Null
